Log in
Enquire now
Immuneering Corporation

Immuneering Corporation

Immuneering Corporation is a Cambridge, Massachusets based company developing treatments for cancer and neurological diseases.

OverviewStructured DataIssuesContributors

Contents

immuneering.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Drug discovery
Drug discovery
Consumer biotechnology
Consumer biotechnology
Genetics
Genetics
Genomics
Genomics
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
...
Location
San Francisco
San Francisco
0
New York
New York
New York City
New York City
0
United States
United States
San Diego
San Diego
0
Cambridge, Massachusetts
Cambridge, Massachusetts
0
CEO
Ben Zeskind
Ben Zeskind
0
Founder
Ben Zeskind
Ben Zeskind
0
Pitchbook URL
pitchbook.com/profiles...121020-85
Legal Name
Immuneering Corporation
Number of Employees (Ranges)
11 – 50
Email Address
info@immuneering.com0
Number of Employees
32
Full Address
245 Main St, 2nd Floor Cambridge, MA 02142, USA0
10864 Thornmint Road San Diego, CA 921270
415 Mission Street, Floor 37 San Francisco, CA 941050
667 Madison Ave New York, NY 100650
CIK Number
1,790,3400
Place of Incorporation
Delaware
Delaware
0
Investors
Cormorant Asset Management
Cormorant Asset Management
LYFE Capital
LYFE Capital
Surveyor Capital
Surveyor Capital
Perceptive Advisors
Perceptive Advisors
Rock Springs Capital
Rock Springs Capital
T. Rowe Price
T. Rowe Price
BlackRock
BlackRock
DUNS Number
8274020530
Founded Date
January 1, 2008
Total Funding Amount (USD)
82,000,000
Latest Funding Round Date
2021
Competitors
Smpl Bio
Smpl Bio
Stock Symbol
IMRX0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
Laurie Keating
Laurie Keating
0
Peter Feinberg
Peter Feinberg
0
Bob Carpenter
Bob Carpenter
0
Diana Hausman
Diana Hausman
0
Ben Zeskind
Ben Zeskind
0
Ann Berman
Ann Berman
0
CFO
Biren Amin
Biren Amin
0
Also Known As
Immuneering
Latest Funding Type
Series B
Series B
CAGE Code
582Q30
Patents Assigned (Count)
1
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Invested in
Cormorant Asset Management
Cormorant Asset Management
T. Rowe Price
T. Rowe Price
Rock Springs Capital
Rock Springs Capital
Surveyor Capital
Surveyor Capital
Latest Funding Round Amount (USD)
62,000,000
SIC Code
2,8340
Ticker Symbol
IMRX
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Immuneering Corporation

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.